ABSCI CORP. news, videos and press releases
For more news please use our advanced search feature.
ABSCI CORP. - More news...
ABSCI CORP. - More news...
- Absci to Participate in Upcoming Investor Conferences
- Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
- Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
- Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
- Absci to Participate in the TD Cowen 45th Annual Health Care Conference
- Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
- Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
- Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
- Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health
- Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
- Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
- Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
- Absci to Host R&D Day on December 12, 2024
- Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
- Absci to Participate in Upcoming Investor Conferences
- Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
- Absci to Participate in Upcoming Investor Conferences
- Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
- Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
- Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
- Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
- Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
- Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
- Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
- Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
